Menu Search
Equities

Cencosud SA

CENCOSUD:SGO

Cencosud SA

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (CLP)1,799.00
  • Today's Change34.00 / 1.93%
  • Shares traded11.89m
  • 1 Year change+19.38%
  • Beta0.8888
Data delayed at least 20 minutes, as of May 15 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-May-23
  • 15-Feb-24
  • 14-Mar-24
  • 18-Apr-24
  • 09-May-24
Select bar for recommendation details.
Recommendations09-May-24
Buy1
Outperform2
Hold7
Underperform1
Sell0

Share price forecast in CLP

The 10 analysts offering 12 month price targets for Cencosud SA have a median target of 1,960.50, with a high estimate of 2,600.00 and a low estimate of 1,390.00. The median estimate represents a 11.08% increase from the last price of 1,765.00.
High47.3%2,600.00
Med11.1%1,960.50
Low-21.2%1,390.00

Dividends in CLP

In 2023, Cencosud SA reported a dividend of 103.00 CLP, which represents a 18.90% decrease from last year. The 3 analysts covering the company expect dividends of 83.06 CLP for the upcoming fiscal year, a decrease of 19.36%.
Div growth (TTM)-18.90%
More ▼

Earnings history & estimates in CLP

On May 02, 2024, Cencosud SA reported 1st quarter 2024 losses of -8.00 per share.
The next earnings announcement is expected on Aug 15, 2024.
Average growth rate+44.17%
Cencosud SA reported annual 2023 earnings of 77.00 per share on Mar 05, 2024.
Average growth rate+456.65%
More ▼

Revenue history & estimates in CLP

Cencosud S.A. had 1st quarter 2024 revenues of 3.94bn. This bettered the 3.74bn consensus of the 2 analysts covering the company. This was 12.41% above the prior year's 1st quarter results.
Average growth rate+3.66%
Cencosud S.A. had revenues for the full year 2023 of 14.23bn. This was 0.20% above the prior year's results.
Average growth rate+11.04%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.